The clinical information you need, at your fingertips.

Some of the heart muscle weakness seen in severely obese patients with heart failure, despite a normal ejection fraction, may improve after treatment that reduces body weight. . .

Elevated lipoprotein(a) remained linked to higher cardiovascular risk even after adjustment for standard therapies and other risk factors. . .

A one-time gene therapy now offers eligible patients the possibility of natural hearing restoration and removes financial barrier through a no-cost access commitment. . .

Early immune targeting offers a chance to delay insulin dependence during critical developmental years. . .

Investigational asundexian reduced recurrent ischemic stroke without increasing major bleeding in a global phase 3 trial. . .

Clinicians now have the first biologic therapy for children as young as two who previously lacked options addressing key disease drivers. . .

Patients with COVID-19 who had an ST-elevation myocardial infarction (STEMI) had substantially higher one-year mortality than similar patients without COVID-19, with excess risk persisting even after discharge. . .

Open-label randomized trial finds adjunctive betamethasone shortens hypoxemia in hospitalized adults. . .

Higher ultra-processed food intake was linked to worse attention and higher modifiable dementia risk, even after accounting for adherence to a Mediterranean-style diet. . .